首页 > 最新文献

Steroids最新文献

英文 中文
Endoplasmic reticulum stress and steroidogenic dysfunction in Leydig cells: Molecular mechanisms of UPR-mediated testosterone regulation 间质细胞内质网应激和类固醇生成功能障碍:uprr介导的睾酮调节的分子机制。
IF 2.3 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-12-08 DOI: 10.1016/j.steroids.2025.109735
Luc J. Martin
This review aims to synthesize current evidence on how endoplasmic reticulum (ER) stress affects steroidogenic function in Leydig cells. It explores the mechanisms by which ER stress activates the unfolded protein response (UPR) and autophagy pathways, ultimately influencing testosterone production and cellular homeostasis. The central research question addresses how ER stress–induced signaling modulates the transcriptional regulation of key steroidogenic enzymes and contributes to age-related declines in androgen synthesis. A comprehensive literature review was conducted using recent findings from molecular, cellular, and animal studies focusing on ER stress signaling in Leydig cells. Studies examining the roles of UPR branches (PERK, IRE1, and ATF6), autophagy pathways, and pharmacological or natural compounds modulating ER stress were analyzed to identify the regulatory mechanisms being involved and potential therapeutic implications. Evidence indicates that unresolved ER stress impairs testosterone biosynthesis by suppressing the expression of genes related to steroidogenesis. Specifically, activations of XBP1, ATF4 and ATF6, as well as their nuclear translocations, may lead to the transcriptional repression of these genes. Conversely, pharmacological ER stress inhibitors and natural antioxidants may restore these protein levels, enhance testosterone production, and improve Leydig cell function. A thorough understanding of the UPR and autophagy in Leydig cells is critical for addressing male reproductive health. ER stress is established as a key factor in the pathophysiology of impaired steroidogenesis. Therefore, targeting these stress response pathways presents a promising strategy for developing novel therapeutic interventions for testosterone deficiency and associated reproductive disorders.
本文综述了内质网应激对间质细胞类固醇生成功能的影响。它探讨了内质网应激激活未折叠蛋白反应(UPR)和自噬途径的机制,最终影响睾酮的产生和细胞稳态。研究的核心问题是内质网应激诱导的信号传导如何调节关键类固醇生成酶的转录调节,并导致与年龄相关的雄激素合成下降。我们利用分子、细胞和动物研究的最新发现对间质细胞内质网应激信号进行了全面的文献综述。研究分析了UPR分支(PERK, IRE1和ATF6),自噬途径以及调节内质网应激的药理学或天然化合物的作用,以确定所涉及的调节机制和潜在的治疗意义。有证据表明,未解决的内质网应激通过抑制激素生成相关基因的表达而损害睾酮的生物合成。具体来说,XBP1、ATF4和ATF6的激活及其核易位可能导致这些基因的转录抑制。相反,内质网应激抑制药物和天然抗氧化剂可以恢复这些蛋白质水平,增加睾酮的产生,改善间质细胞的功能。全面了解普遍定期循环和间质细胞的自噬对解决男性生殖健康问题至关重要。内质网应激已被确定为类固醇生成受损病理生理的关键因素。因此,针对这些应激反应途径提出了一个有希望的策略,为开发新的治疗干预睾丸激素缺乏和相关生殖障碍。
{"title":"Endoplasmic reticulum stress and steroidogenic dysfunction in Leydig cells: Molecular mechanisms of UPR-mediated testosterone regulation","authors":"Luc J. Martin","doi":"10.1016/j.steroids.2025.109735","DOIUrl":"10.1016/j.steroids.2025.109735","url":null,"abstract":"<div><div>This review aims to synthesize current evidence on how endoplasmic reticulum (ER) stress affects steroidogenic function in Leydig cells. It explores the mechanisms by which ER stress activates the unfolded protein response (UPR) and autophagy pathways, ultimately influencing testosterone production and cellular homeostasis. The central research question addresses how ER stress–induced signaling modulates the transcriptional regulation of key steroidogenic enzymes and contributes to age-related declines in androgen synthesis. A comprehensive literature review was conducted using recent findings from molecular, cellular, and animal studies focusing on ER stress signaling in Leydig cells. Studies examining the roles of UPR branches (PERK, IRE1, and ATF6), autophagy pathways, and pharmacological or natural compounds modulating ER stress were analyzed to identify the regulatory mechanisms being involved and potential therapeutic implications. Evidence indicates that unresolved ER stress impairs testosterone biosynthesis by suppressing the expression of genes related to steroidogenesis. Specifically, activations of XBP1, ATF4 and ATF6, as well as their nuclear translocations, may lead to the transcriptional repression of these genes. Conversely, pharmacological ER stress inhibitors and natural antioxidants may restore these protein levels, enhance testosterone production, and improve Leydig cell function. A thorough understanding of the UPR and autophagy in Leydig cells is critical for addressing male reproductive health. ER stress is established as a key factor in the pathophysiology of impaired steroidogenesis. Therefore, targeting these stress response pathways presents a promising strategy for developing novel therapeutic interventions for testosterone deficiency and associated reproductive disorders.</div></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":"226 ","pages":"Article 109735"},"PeriodicalIF":2.3,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of reproductive steroids on autosomal dominant polycystic kidney disease progression in women 生殖类固醇对女性常染色体显性多囊肾病进展的影响
IF 2.3 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-12-05 DOI: 10.1016/j.steroids.2025.109726
Noor Saeed Hasan, Warren Thomas
Autosomal dominant polycystic kidney disease (ADPKD) is a disease characterized by the growth of fluid filled cysts in the kidney. ADPKD arises due to a heritable mutation in the polycystic kidney disease 1 gene (PKD1) and polycystic kidney disease 2 gene (PKD2) ultimately leading to kidney failure. Incidence in males and females is equivalent, but differences arise in progression. This review brings together various studies regarding the impact of cyclic hormone changes on ADPKD progression, bringing attention to gaps in knowledge that needs to be addressed. Circulating hormones play a crucial role in the pathogenesis of the disease, particularly the renin angiotensin system. The physiological actions of estrogen tend to have a protective effect on the kidney, contributing to a slowed progression in females. The hormonal changes of the menstrual cycle and at menopause result in changes in pathology via blood pressure fluctuation, promotion of renal repair and prevention of renal scarring and damage. Signaling pathways that are involved in cyst growth such as cAMP, mTOR, MAPK/ERK, and PI3K/Akt are modulated by estrogen, providing insights into potential mechanisms. Estrogen-based hormonal therapy is being investigated for its efficacy in improving renal function post menopause.
常染色体显性多囊肾病(ADPKD)是一种以肾脏中充满液体的囊肿生长为特征的疾病。ADPKD是由多囊肾病1基因(PKD1)和多囊肾病2基因(PKD2)的遗传突变引起的,最终导致肾衰竭。男性和女性的发病率是相等的,但在进展中会出现差异。这篇综述汇集了关于循环激素变化对ADPKD进展影响的各种研究,引起了人们对需要解决的知识空白的关注。循环激素在疾病的发病机制中起着至关重要的作用,特别是肾素血管紧张素系统。雌激素的生理作用往往对肾脏有保护作用,有助于减缓女性的进展。月经周期和绝经期的激素变化通过血压波动、促进肾脏修复和预防肾脏瘢痕和损伤导致病理变化。参与囊肿生长的信号通路,如cAMP、mTOR、MAPK/ERK、PI3K/Akt等,均受雌激素调控,为进一步了解其潜在机制提供了依据。以雌激素为基础的激素治疗正在研究其改善绝经后肾功能的功效。
{"title":"The impact of reproductive steroids on autosomal dominant polycystic kidney disease progression in women","authors":"Noor Saeed Hasan,&nbsp;Warren Thomas","doi":"10.1016/j.steroids.2025.109726","DOIUrl":"10.1016/j.steroids.2025.109726","url":null,"abstract":"<div><div>Autosomal dominant polycystic kidney disease (ADPKD) is a disease characterized by the growth of fluid filled cysts in the kidney. ADPKD arises due to a heritable mutation in the polycystic kidney disease 1 gene (PKD1) and polycystic kidney disease 2 gene (PKD2) ultimately leading to kidney failure. Incidence in males and females is equivalent, but differences arise in progression. This review brings together various studies regarding the impact of cyclic hormone changes on ADPKD progression, bringing attention to gaps in knowledge that needs to be addressed. Circulating hormones play a crucial role in the pathogenesis of the disease, particularly the renin angiotensin system. The physiological actions of estrogen tend to have a protective effect on the kidney, contributing to a slowed progression in females. The hormonal changes of the menstrual cycle and at menopause result in changes in pathology via blood pressure fluctuation, promotion of renal repair and prevention of renal scarring and damage. Signaling pathways that are involved in cyst growth such as cAMP, mTOR, MAPK/ERK, and PI3K/Akt are modulated by estrogen, providing insights into potential mechanisms. Estrogen-based hormonal therapy is being investigated for its efficacy in improving renal function post menopause.</div></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":"226 ","pages":"Article 109726"},"PeriodicalIF":2.3,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145701625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An unexpected oxidative E/F ring opening in the side chain of steroid sapogenins produced by silica gel supported Jones Reagent 用硅胶支撑的琼斯试剂制备甾体皂苷元侧链上出现意外的氧化E/F环开口。
IF 2.3 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-11-27 DOI: 10.1016/j.steroids.2025.109725
Juan E. Hernández-Martínez, Karen M. Ruíz-Pérez, Jacqueline Sanchez-Flores, Martin A. Iglesias-Arteaga
In contrast with previous results in which the spiroketal side chain of steroid sapogenin has proven to be unreactive to Jones Reagent, treatment these sapogenins with silica gel-supported Jones Reagent triggered the oxidative opening of the spirostanic side chain producing moderate to good yields of sapogenoic acids that bear carbonyl functions at C-16 and C-22 and a C-26 carboxylic group. Based on these findings, a procedure that allows the synthesis of sapogenoic acids minimizing contamination by chromium salts was designed.
与之前的结果相反,类固醇皂苷元的螺旋形侧链已被证明对琼斯试剂无反应,用硅胶支撑的琼斯试剂处理这些皂苷元触发螺旋形侧链的氧化打开,产生中等到良好产量的皂苷酸,这些皂苷酸具有C-16和C-22的羰基功能和C-26的羧基。基于这些发现,设计了一种程序,允许合成皂苷酸,最大限度地减少铬盐的污染。
{"title":"An unexpected oxidative E/F ring opening in the side chain of steroid sapogenins produced by silica gel supported Jones Reagent","authors":"Juan E. Hernández-Martínez,&nbsp;Karen M. Ruíz-Pérez,&nbsp;Jacqueline Sanchez-Flores,&nbsp;Martin A. Iglesias-Arteaga","doi":"10.1016/j.steroids.2025.109725","DOIUrl":"10.1016/j.steroids.2025.109725","url":null,"abstract":"<div><div>In contrast with previous results in which the spiroketal side chain of steroid sapogenin has proven to be unreactive to Jones Reagent, treatment these sapogenins with silica gel-supported Jones Reagent triggered the oxidative opening of the spirostanic side chain producing moderate to good yields of sapogenoic acids that bear carbonyl functions at C-16 and C-22 and a C-26 carboxylic group. Based on these findings, a procedure that allows the synthesis of sapogenoic acids minimizing contamination by chromium salts was designed.</div></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":"226 ","pages":"Article 109725"},"PeriodicalIF":2.3,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145640036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LC-MS/MS quantitation of the primary reduced metabolites of progesterone in serum during the third trimester of human pregnancy reveals a potential role for 20β-hydroxyprogesterone and 5β-dihydroprogesterone in functional progesterone withdrawal LC-MS/MS定量测定人类妊娠晚期血清中孕酮的主要还原代谢产物揭示了20β-羟孕酮和5β-二氢孕酮在功能性孕酮停药中的潜在作用
IF 2.3 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-11-24 DOI: 10.1016/j.steroids.2025.109724
Edward Hinchliffe , Alexander Heazell
Progesterone (P4) is an essential steroid hormone synthesised by the placenta required for the maintenance of pregnancy. In humans, the metabolism of P4 has been implicated in functional P4 withdrawal prior to parturition. We have developed a novel liquid chromatography tandem mass spectrometry (LC-MS/MS) method for quantitation in human serum of pregnenolone, P4 and its four primary reduced metabolites; 20α-hydroxyprogesterone (20α-OHP), 20β-hydroxyprogesterone (20β-OHP), 5α-dihydroprogesterone (5α-DHP) and 5β-dihydroprogesterone (5β-DHP). Following solid phase extraction, chromatographic baseline separation of each steroid was achieved using a biphenyl stationary phase within a 10.0 min runtime, followed by MS detection on a Sciex 6500+. The LC-MS/MS method was validated in accordance with published guidelines, confirming acceptable analytical performance pertaining to linearity, imprecision, accuracy, sensitivity, matrix effects, specificity and carryover. The method was applied to a large cohort of third trimester pregnancies with verified uncomplicated neonatal outcomes. Maternal circulating concentrations of P4, 20α-OHP, 20β-OHP, and 5α-DHP positively correlated with fetal gestational age. The ratio of P4:20β-OHP declined significantly throughout the third trimester, whilst the ratio of P4:5β-DHP increased at full term from 40 weeks’ gestation. These findings may indicate a substantive role for β-reduction of P4 in the mechanics of functional P4 withdrawal, either via depletion of the overall pool of bioactive P4 or competitive binding of these metabolites to the P4 receptor in maternal and fetal tissue. Additionally, detailed characterisation of the normal maternal steroidome will facilitate the study of dysregulated placental steroidogenesis, which has been implicated in the pathogenesis of the major obstetric syndromes causing poor pregnancy outcomes.
黄体酮(P4)是由胎盘合成的维持妊娠所需的必需类固醇激素。在人类中,P4的代谢与分娩前P4的功能性戒断有关。建立了一种新的液相色谱-串联质谱(LC-MS/MS)测定人血清中孕烯醇酮、P4及其四种主要还原代谢物的方法;20α-羟孕酮(20α-OHP)、20β-羟孕酮(20β-OHP)、5α-二氢孕酮(5α-DHP)和5β-二氢孕酮(5β-DHP)。固相萃取后,使用联苯固定相在10.0 min的运行时间内实现每种类固醇的色谱基线分离,然后在Sciex 6500+上进行质谱检测。根据发布的指南对LC-MS/MS方法进行了验证,确认了与线性、不精密度、准确性、灵敏度、基质效应、特异性和结转有关的可接受的分析性能。该方法应用于一个大队列的晚期妊娠证实无并发症的新生儿结局。母体循环P4、20α-OHP、20β-OHP、5α-DHP浓度与胎龄呈正相关。P4:20β-OHP比值在妊娠晚期显著下降,而P4:5β-DHP比值从妊娠40周开始在足月升高。这些发现可能表明β-减少P4在P4功能性戒断机制中的实质性作用,可能是通过耗尽P4的整体生物活性库,也可能是通过母体和胎儿组织中这些代谢物与P4受体的竞争性结合。此外,对正常母体甾体激素的详细描述将有助于研究胎盘甾体生成失调,这与导致妊娠结局不良的主要产科综合征的发病机制有关。
{"title":"LC-MS/MS quantitation of the primary reduced metabolites of progesterone in serum during the third trimester of human pregnancy reveals a potential role for 20β-hydroxyprogesterone and 5β-dihydroprogesterone in functional progesterone withdrawal","authors":"Edward Hinchliffe ,&nbsp;Alexander Heazell","doi":"10.1016/j.steroids.2025.109724","DOIUrl":"10.1016/j.steroids.2025.109724","url":null,"abstract":"<div><div>Progesterone (P4) is an essential steroid hormone synthesised by the placenta required for the maintenance of pregnancy. In humans, the metabolism of P4 has been implicated in functional P4 withdrawal prior to parturition. We have developed a novel liquid chromatography tandem mass spectrometry (LC-MS/MS) method for quantitation in human serum of pregnenolone, P4 and its four primary reduced metabolites; 20α-hydroxyprogesterone (20α-OHP), 20β-hydroxyprogesterone (20β-OHP), 5α-dihydroprogesterone (5α-DHP) and 5β-dihydroprogesterone (5β-DHP). Following solid phase extraction, chromatographic baseline separation of each steroid was achieved using a biphenyl stationary phase within a 10.0 min runtime, followed by MS detection on a Sciex 6500+. The LC-MS/MS method was validated in accordance with published guidelines, confirming acceptable analytical performance pertaining to linearity, imprecision, accuracy, sensitivity, matrix effects, specificity and carryover. The method was applied to a large cohort of third trimester pregnancies with verified uncomplicated neonatal outcomes. Maternal circulating concentrations of P4, 20α-OHP, 20β-OHP, and 5α-DHP positively correlated with fetal gestational age. The ratio of P4:20β-OHP declined significantly throughout the third trimester, whilst the ratio of P4:5β-DHP increased at full term from 40 weeks’ gestation. These findings may indicate a substantive role for β-reduction of P4 in the mechanics of functional P4 withdrawal, either via depletion of the overall pool of bioactive P4 or competitive binding of these metabolites to the P4 receptor in maternal and fetal tissue. Additionally, detailed characterisation of the normal maternal steroidome will facilitate the study of dysregulated placental steroidogenesis, which has been implicated in the pathogenesis of the major obstetric syndromes causing poor pregnancy outcomes.</div></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":"225 ","pages":"Article 109724"},"PeriodicalIF":2.3,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145615351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Semi-synthetic sapogenin derivatives inhibit inflammation-induced tumorigenic signaling alterations in prostate carcinogenesis 半合成皂苷元衍生物抑制前列腺癌发生中炎症诱导的致瘤信号改变。
IF 2.3 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-11-23 DOI: 10.1016/j.steroids.2025.109723
Bilge Debelec-Butuner , Mert Burak Ozturk , Ozgur Tag , Ismail Hakki Akgun , Erdal Bedir
Prostatic inflammation plays a pivotal role in prostate cancer development and progression via altering key cellular mechanisms, including proliferation, metastasis, and angiogenesis. Therefore, the use of anti-inflammatory drugs could provide a valid contribution to PCa prevention and treatment. In our research, we explored semi-synthetic derivatives of cycloastragenol (CA) and astragenol (AG) to assess their potential to inhibit inflammation-mediated tumorigenic signaling.
Building on our previous findings, which demonstrated their inhibitory activity on NFκB, we discovered that these molecules also suppress inflammation-induced cell proliferation and migration through distinct mechanisms. They effectively alleviated inflammation by reducing levels of ROS, NO, and VEGF expression. Furthermore, these molecules partially restored the expression of AR and the tumor suppressor NKX3.1, both of which are critical in prostate tumorigenesis within an inflammatory microenvironment. They also reversed inflammation-induced activation of Akt and β-catenin signaling, suggesting their potential to inhibit inflammation-related prostate tumorigenesis. Our study further demonstrated that these molecules exhibited dose-dependent effects on inducing cell cycle arrest and apoptosis, as evidenced by increased p21 and decreased BCL-2 protein levels, leading to activated cell death and suppressed cellular migration.
In conclusion, these semi-synthetic sapogenol derivatives demonstrate significant potential as anti-inflammatory and anticancer agents, offering a promising approach for targeting prostatic inflammation and inflammation-driven prostate carcinogenesis.
前列腺炎症通过改变关键的细胞机制,包括增殖、转移和血管生成,在前列腺癌的发生和发展中起着关键作用。因此,使用抗炎药物可以为PCa的预防和治疗提供有效的贡献。在我们的研究中,我们探索了环黄芪醇(CA)和黄芪醇(AG)的半合成衍生物,以评估它们抑制炎症介导的致瘤信号传导的潜力。在我们之前的研究结果的基础上,我们发现这些分子对NFκB具有抑制活性,我们发现这些分子也通过不同的机制抑制炎症诱导的细胞增殖和迁移。它们通过提高ROS、NO和VEGF的表达水平有效地减轻炎症。此外,这些分子部分恢复了AR和肿瘤抑制因子NKX3.1的表达,这两者在炎症微环境下的前列腺肿瘤发生中都是至关重要的。它们还逆转了炎症诱导的Akt和β-catenin信号的激活,表明它们有抑制炎症相关前列腺肿瘤发生的潜力。我们的研究进一步证明,这些分子在诱导细胞周期阻滞和凋亡方面表现出剂量依赖性,p21升高,BCL-2蛋白水平降低,导致细胞活化死亡,抑制细胞迁移。总之,这些半合成皂苷醇衍生物显示出作为抗炎和抗癌药物的巨大潜力,为针对前列腺炎症和炎症驱动的前列腺癌提供了一种有希望的方法。
{"title":"Semi-synthetic sapogenin derivatives inhibit inflammation-induced tumorigenic signaling alterations in prostate carcinogenesis","authors":"Bilge Debelec-Butuner ,&nbsp;Mert Burak Ozturk ,&nbsp;Ozgur Tag ,&nbsp;Ismail Hakki Akgun ,&nbsp;Erdal Bedir","doi":"10.1016/j.steroids.2025.109723","DOIUrl":"10.1016/j.steroids.2025.109723","url":null,"abstract":"<div><div>Prostatic inflammation plays a pivotal role in prostate cancer development and progression via altering key cellular mechanisms, including proliferation, metastasis, and angiogenesis. Therefore, the use of anti-inflammatory drugs could provide a valid contribution to PCa prevention and treatment. In our research, we explored semi-synthetic derivatives of cycloastragenol (<strong>CA</strong>) and astragenol (<strong>AG</strong>) to assess their potential to inhibit inflammation-mediated tumorigenic signaling.</div><div>Building on our previous findings, which demonstrated their inhibitory activity on NFκB, we discovered that these molecules also suppress inflammation-induced cell proliferation and migration through distinct mechanisms. They effectively alleviated inflammation by reducing levels of ROS, NO, and VEGF expression. Furthermore, these molecules partially restored the expression of AR and the tumor suppressor NKX3.1, both of which are critical in prostate tumorigenesis within an inflammatory microenvironment. They also reversed inflammation-induced activation of Akt and β-catenin signaling, suggesting their potential to inhibit inflammation-related prostate tumorigenesis. Our study further demonstrated that these molecules exhibited dose-dependent effects on inducing cell cycle arrest and apoptosis, as evidenced by increased p21 and decreased BCL-2 protein levels, leading to activated cell death and suppressed cellular migration.</div><div>In conclusion, these semi-synthetic sapogenol derivatives demonstrate significant potential as anti-inflammatory and anticancer agents, offering a promising approach for targeting prostatic inflammation and inflammation-driven prostate carcinogenesis.</div></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":"225 ","pages":"Article 109723"},"PeriodicalIF":2.3,"publicationDate":"2025-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145605725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antifungal ergostane-type steroids from endophytic fungus Xylaria sp. VDL4 内生真菌Xylaria sp. VDL4抗真菌麦角酮型类固醇。
IF 2.3 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-11-22 DOI: 10.1016/j.steroids.2025.109722
Jiao Yao , Lin-Hong Lu , Sheng-Yun Wei , Ting Wu , Wei Yang , Wei-Hua Wang , Fa-Zhong Yang , Yun-Xian Li , Ping Zhao , Guo-Lei Zhu
Three ergostane-type steroids, including one rare C-29 methylated xylarstane A (1) and one C22,23-epoxied xylarstane B (2), along with one reported compound 3, were isolated from the endophytic fungus Xylaria sp. VDL4 harbored within the medicinal plant Vaccinium dunalianum. The structures of novel compounds were elucidated through comprehensive spectroscopic analysis, DP4+-validated theoretical 13C nuclear magnetic resonance (NMR) calculations, and electronic circular dichroism (ECD) calculations. The antifungal activities of the isolates against four phytopathogens were assessed in vitro. Compounds 1 and 3 exerted significant inhibition against Alternaria solani and Botrytis cinerea respectively, both with minimal inhibitory concentration (MIC) of 12.5 μg/mL, comparing with the positive control (Carbendazim and Thiabendazole, MICs = 12.5–25.0 μg/mL).
从药用植物dunalianum中的内生真菌Xylaria sp. VDL4中分离到3个麦角甾类化合物,包括1个罕见的C-29甲基化木larstane A(1)和1个C22,23-环氧化木larstane B(2),以及1个已报道的化合物3。通过综合光谱分析、DP4+验证的理论13C核磁共振(NMR)计算和电子圆二色性(ECD)计算,对新化合物的结构进行了阐明。体外鉴定了分离物对4种植物病原菌的抑菌活性。与阳性对照(多菌灵和噻苯达唑,MIC = 12.5 ~ 25.0 μg/mL)相比,化合物1和3对番茄赤霉和灰霉菌分别具有显著的抑制作用,最小抑制浓度(MIC)均为12.5 μg/mL。
{"title":"Antifungal ergostane-type steroids from endophytic fungus Xylaria sp. VDL4","authors":"Jiao Yao ,&nbsp;Lin-Hong Lu ,&nbsp;Sheng-Yun Wei ,&nbsp;Ting Wu ,&nbsp;Wei Yang ,&nbsp;Wei-Hua Wang ,&nbsp;Fa-Zhong Yang ,&nbsp;Yun-Xian Li ,&nbsp;Ping Zhao ,&nbsp;Guo-Lei Zhu","doi":"10.1016/j.steroids.2025.109722","DOIUrl":"10.1016/j.steroids.2025.109722","url":null,"abstract":"<div><div>Three ergostane-type steroids, including one rare C-29 methylated xylarstane A (<strong>1</strong>) and one C22,23-epoxied xylarstane B (<strong>2</strong>), along with one reported compound <strong>3</strong>, were isolated from the endophytic fungus <em>Xylaria</em> sp. VDL4 harbored within the medicinal plant <em>Vaccinium dunalianum</em>. The structures of novel compounds were elucidated through comprehensive spectroscopic analysis, DP4<sup>+</sup>-validated theoretical <sup>13</sup>C nuclear magnetic resonance (NMR) calculations, and electronic circular dichroism (ECD) calculations. The antifungal activities of the isolates against four phytopathogens were assessed <em>in vitro.</em> Compounds <strong>1</strong> and <strong>3</strong> exerted significant inhibition against <em>Alternaria solani</em> and <em>Botrytis cinerea</em> respectively, both with minimal inhibitory concentration (MIC) of 12.5 μg/mL, comparing with the positive control (Carbendazim and Thiabendazole, MICs = 12.5–25.0 μg/mL).</div></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":"225 ","pages":"Article 109722"},"PeriodicalIF":2.3,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145597679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro metabolic profiling of 6-chloro-testosterone and 6-ene-testosterone by liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-time of flight (GC-TOF) mass spectrometry 液相色谱-质谱(LC-MS)和气相色谱-飞行时间(GC-TOF)质谱法研究6-氯-睾酮和6-烯-睾酮的体外代谢谱。
IF 2.3 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.steroids.2025.109720
Dayamin Martínez_Brito , Carlotta Stacchini , Cristiana Colamonici , Davide Curcio , Francesco Botrè , Xavier de la Torre
Among the phase-I reactions of 6-chloro-testosterone (6-CT), the reductive and oxidative dehalogenation, as well as the dehydrogenation, have been described here. One of the metabolic products could be the 6-ene-testosterone (6-ene-T). The goal of this work was to study the in vitro metabolism of 6-CT and 6-ene-T after incubation with human liver microsomes (HLM), analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and gas chromatography-time-of-flight-mass spectrometry (GC-TOF).
6-CT showed a more extensive metabolism compared to 6-ene-T, with the formation of a larger number of metabolites. In contrast, 6-ene-T, which potentially preserves the C6C7 double bond in most of its metabolites, showed fewer metabolites. Therefore, after incubation with HLM, the main metabolic routes of 6-ene-T are the oxidation of the hydroxyl group on C17β, retaining the double bond C6C7 to form 6-ene-androstenedione, and the hydroxylation on C6. On the other hand 6-CT metabolism produced chlorinated and non-chlorinated metabolites as a result of the phase I reactions which included oxidation, reduction, hydroxylation and (oxidative and reductive) dehalogenation. Specifically for 6-CT, it should be considered that the introduction of a chlorine atom in the 6α position of T may lead to a shift in the metabolic pathway, favoring the formation of 5β-reduced metabolites over 5α-reduced metabolites, due to the steric and electronic effects of the chlorine atom on the interaction between the steroid molecule and the 5α-reductase enzyme.
在6-氯-睾酮(6-CT)的i相反应中,本文描述了还原和氧化脱卤以及脱氢反应。代谢产物之一可能是6-烯-睾酮(6-烯-t)。采用液相色谱-串联质谱(LC-MS/MS)和气相色谱-飞行时间质谱(GC-TOF)分析6-CT和6-烯-t与人肝微粒体(HLM)孵育后的体外代谢情况。与6-ene-T相比,6-CT显示代谢更广泛,形成的代谢物数量更多。相比之下,在大多数代谢物中潜在地保留C6C7双键的6-ene-T的代谢物较少。因此,经HLM培养后,6-烯- t的主要代谢途径是C17β上的羟基氧化,保留双键C6C7形成6-烯-雄烯二酮,以及C6上的羟基化。另一方面,6-CT代谢产生氯化和非氯化代谢物是I相反应的结果,包括氧化、还原、羟基化和(氧化和还原)脱卤。具体到6-CT,由于氯原子对类固醇分子与5α-还原酶的相互作用具有空间位和电子效应,因此在T的6α位置引入氯原子可能导致代谢途径发生转变,更倾向于生成5β-还原代谢物而不是5α-还原代谢物。
{"title":"In vitro metabolic profiling of 6-chloro-testosterone and 6-ene-testosterone by liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-time of flight (GC-TOF) mass spectrometry","authors":"Dayamin Martínez_Brito ,&nbsp;Carlotta Stacchini ,&nbsp;Cristiana Colamonici ,&nbsp;Davide Curcio ,&nbsp;Francesco Botrè ,&nbsp;Xavier de la Torre","doi":"10.1016/j.steroids.2025.109720","DOIUrl":"10.1016/j.steroids.2025.109720","url":null,"abstract":"<div><div>Among the phase-I reactions of 6-chloro-testosterone (6-CT), the reductive and oxidative dehalogenation, as well as the dehydrogenation, have been described here. One of the metabolic products could be the 6-ene-testosterone (6-ene-T). The goal of this work was to study the <em>in vitro</em> metabolism of 6-CT and 6-ene-T after incubation with human liver microsomes (HLM), analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and gas chromatography-time-of-flight-mass spectrometry (GC-TOF).</div><div>6-CT showed a more extensive metabolism compared to 6-ene-T, with the formation of a larger number of metabolites. In contrast, 6-ene-T, which potentially preserves the C6<img>C7 double bond in most of its metabolites, showed fewer metabolites. Therefore, after incubation with HLM, the main metabolic routes of 6-ene-T are the oxidation of the hydroxyl group on C17β, retaining the double bond C6<img>C7 to form 6-ene-androstenedione, and the hydroxylation on C6. On the other hand 6-CT metabolism produced chlorinated and non-chlorinated metabolites as a result of the phase I reactions which included oxidation, reduction, hydroxylation and (oxidative and reductive) dehalogenation. Specifically for 6-CT, it should be considered that the introduction of a chlorine atom in the 6α position of T may lead to a shift in the metabolic pathway, favoring the formation of 5β-reduced metabolites over 5α-reduced metabolites, due to the steric and electronic effects of the chlorine atom on the interaction between the steroid molecule and the 5α-reductase enzyme.</div></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":"225 ","pages":"Article 109720"},"PeriodicalIF":2.3,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year children 4- 7岁以下儿童血清生物标志物对游离性皮质甾体抗炎药——氨莫洛酮的暴露反应
IF 2.3 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.steroids.2025.109721
Swati Mummidivarpu , Utkarsh J. Dang , Michael Ziemba , Yetrib Hathout , Paula R. Clemens , Jesse Damsker , Laura Hagerty , William J. Jusko , Edward C. Smith , Jean K. Mah , Michela Guglieri , Yoram Nevo , Nancy Kuntz , Craig M. McDonald , Monique M. Ryan , Diana Castro , Richard S. Finkel , Laurie S. Conklin , John M. McCall , Kanneboyina Nagaraju , Eric P. Hoffman

Objectives

Corticosteroid agonists of the glucocorticoid receptor are a mainstay of therapeutics for pro-inflammatory conditions. Vamorolone is a novel partial agonist that is differentiated from the other members of the corticosteroid class by non-metabolism by 11β-hydroxysteroid dehydrogenases, antagonism of the mineralocorticoid receptor, and differential co-factor binding. Our objective was to define the pharmacodynamic response of serum proteins to vamorolone.

Methods

Clinical trial participants with Duchenne muscular dystrophy (4 to <7 yr; n = 39; mean [SD] age = 5.3 [1.0]) enrolled in a multiple ascending dose study of vamorolone were studied (24-fold dose range). Dose-response and exposure–response of 1,305 serum proteins were defined by intra-subject longitudinal changes (baseline vs. Day 14).

Results

Dose-response analysis identified 159 of 1,305 serum proteins as dose-responsive to vamorolone (12 % of proteins tested; 20 % increased, 80 % decreased). Two inflammatory networks showed drug-responsive suppression. One centered on extracellular serine proteases and lymphotoxins (PI3, KLK7, KLK8, KLK11, lymphotoxins A, B) converging on NFκB. The second centered on cytokines (CCL22/MDC, CCL21, CCL14, CXCL12) and IL23 signaling. In the IL23 network, acutely responsive anti-inflammatory proteins included increases of an inhibitor of IL17 signaling (IL17RC) and decreases of IL23 (IL12B:IL23A). A protein associated with resistance to environmental microbes, PTP1C, showed strong induction and is a novel candidate for aspects of corticosteroid efficacy. Two networks of cell-associated proteins were identified as drug responsive that may represent muscle tissue response (efficacy): connective tissue remodeling upstream of Notch signaling, and plasma membrane proteins impinging on AKT1 signaling.

Conclusion

The serum proteome pharmacodynamics of the response to vamorolone was defined.
目的:糖皮质激素受体的皮质类固醇激动剂是治疗促炎条件的主要药物。Vamorolone是一种新型的部分激动剂,与其他皮质类固醇类药物不同,它不被11β-羟基类固醇脱氢酶代谢,对矿物皮质激素受体具有拮抗作用,并与差异辅因子结合。我们的目的是确定血清蛋白对氨摩洛酮的药效学反应。结果:剂量反应分析发现1305种血清蛋白中有159种对氨莫洛酮有剂量反应(12% %检测蛋白,20% %升高,80% %降低)。两个炎症网络显示药物反应性抑制。一个集中在细胞外丝氨酸蛋白酶和淋巴毒素(PI3, KLK7, KLK8, KLK11,淋巴毒素A, B)上,它们聚集在NFκB上。第二个集中于细胞因子(CCL22/MDC, CCL21, CCL14, CXCL12)和il - 23信号。在il - 23网络中,急性反应性抗炎蛋白包括il - 17信号抑制剂(IL17RC)的增加和il - 23 (IL12B:IL23A)的减少。一种与环境微生物耐药性相关的蛋白PTP1C显示出很强的诱导作用,是皮质类固醇疗效方面的新候选蛋白。两个细胞相关蛋白网络被确定为药物反应,可能代表肌肉组织反应(功效):Notch信号上游的结缔组织重塑和影响AKT1信号的质膜蛋白。结论:确定了对氨莫洛酮反应的血清蛋白质组药效学。
{"title":"Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year children","authors":"Swati Mummidivarpu ,&nbsp;Utkarsh J. Dang ,&nbsp;Michael Ziemba ,&nbsp;Yetrib Hathout ,&nbsp;Paula R. Clemens ,&nbsp;Jesse Damsker ,&nbsp;Laura Hagerty ,&nbsp;William J. Jusko ,&nbsp;Edward C. Smith ,&nbsp;Jean K. Mah ,&nbsp;Michela Guglieri ,&nbsp;Yoram Nevo ,&nbsp;Nancy Kuntz ,&nbsp;Craig M. McDonald ,&nbsp;Monique M. Ryan ,&nbsp;Diana Castro ,&nbsp;Richard S. Finkel ,&nbsp;Laurie S. Conklin ,&nbsp;John M. McCall ,&nbsp;Kanneboyina Nagaraju ,&nbsp;Eric P. Hoffman","doi":"10.1016/j.steroids.2025.109721","DOIUrl":"10.1016/j.steroids.2025.109721","url":null,"abstract":"<div><h3>Objectives</h3><div>Corticosteroid agonists of the glucocorticoid receptor are a mainstay of therapeutics for pro-inflammatory conditions. Vamorolone is a novel partial agonist that is differentiated from the other members of the corticosteroid class by non-metabolism by 11β-hydroxysteroid dehydrogenases, antagonism of the mineralocorticoid receptor, and differential co-factor binding. Our objective was to define the pharmacodynamic response of serum proteins to vamorolone.</div></div><div><h3>Methods</h3><div>Clinical trial participants with Duchenne muscular dystrophy (4 to &lt;7 yr; n = 39; mean [SD] age = 5.3 [1.0]) enrolled in a multiple ascending dose study of vamorolone were studied (24-fold dose range). Dose-response and exposure–response of 1,305 serum proteins were defined by intra-subject longitudinal changes (baseline vs. Day 14).</div></div><div><h3>Results</h3><div>Dose-response analysis identified 159 of 1,305 serum proteins as dose-responsive to vamorolone (12 % of proteins tested; 20 % increased, 80 % decreased). Two inflammatory networks showed drug-responsive suppression. One centered on extracellular serine proteases and lymphotoxins (PI3, KLK7, KLK8, KLK11, lymphotoxins A, B) converging on NFκB. The second centered on cytokines (CCL22/MDC, CCL21, CCL14, CXCL12) and IL23 signaling. In the IL23 network, acutely responsive anti-inflammatory proteins included increases of an inhibitor of IL17 signaling (IL17RC) and decreases of IL23 (IL12B:IL23A). A protein associated with resistance to environmental microbes, PTP1C, showed strong induction and is a novel candidate for aspects of corticosteroid efficacy. Two networks of cell-associated proteins were identified as drug responsive that may represent muscle tissue response (efficacy): connective tissue remodeling upstream of Notch signaling, and plasma membrane proteins impinging on AKT1 signaling.</div></div><div><h3>Conclusion</h3><div>The serum proteome pharmacodynamics of the response to vamorolone was defined.</div></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":"225 ","pages":"Article 109721"},"PeriodicalIF":2.3,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discovery of dihydrobetulinic acid as a potent small molecule CD73 inhibitor 二氢白桦酸作为一种有效的CD73小分子抑制剂的发现。
IF 2.3 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.steroids.2025.109719
Hongling Wang , Yanming Zhang , Chunyang Lou , Xuliang Chang , Hang Yang , Daozuan Zhang , Haijun Ma , Zhenyuan Miao
Betulinic acid (BA) is a pentacyclic triterpene compound with various biological activities. Herein, we designed and synthesized a series of dihydrobetulinic acid (DHBA) and its derivatives for the discovery of potent ecto-5′-nucleotidase (CD73) inhibitors. Biological evaluation of DHBA and its derivatives led to the disclosure of three active compounds DHBA, ZM792 and ZM905. Further investigation of antitumor immunity revealed that DHBA could effectively restore the function of CD4+ T cells. These results provide novel insights for future endeavors in developing novel agents derived from natural product targeting CD73 enzyme.
白桦酸(BA)是一种具有多种生物活性的五环三萜化合物。在此,我们设计并合成了一系列二氢白桦酸(DHBA)及其衍生物,以发现有效的外5'-核苷酸酶(CD73)抑制剂。通过对DHBA及其衍生物的生物学评价,发现了三种活性化合物DHBA、ZM792和ZM905。进一步的抗肿瘤免疫研究发现,DHBA能有效恢复CD4+ T细胞的功能。这些结果为未来开发靶向CD73酶的天然产物衍生的新型药物提供了新的见解。
{"title":"Discovery of dihydrobetulinic acid as a potent small molecule CD73 inhibitor","authors":"Hongling Wang ,&nbsp;Yanming Zhang ,&nbsp;Chunyang Lou ,&nbsp;Xuliang Chang ,&nbsp;Hang Yang ,&nbsp;Daozuan Zhang ,&nbsp;Haijun Ma ,&nbsp;Zhenyuan Miao","doi":"10.1016/j.steroids.2025.109719","DOIUrl":"10.1016/j.steroids.2025.109719","url":null,"abstract":"<div><div>Betulinic acid (BA) is a pentacyclic triterpene compound with various biological activities. Herein, we designed and synthesized a series of dihydrobetulinic acid (DHBA) and its derivatives for the discovery of potent ecto-5′-nucleotidase (CD73) inhibitors. Biological evaluation of DHBA and its derivatives led to the disclosure of three active compounds DHBA, <strong>ZM792</strong> and <strong>ZM905</strong>. Further investigation of antitumor immunity revealed that DHBA could effectively restore the function of CD4<sup>+</sup> T cells. These results provide novel insights for future endeavors in developing novel agents derived from natural product targeting CD73 enzyme.</div></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":"225 ","pages":"Article 109719"},"PeriodicalIF":2.3,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective effect of vitamin D on high-fat-diet-induced metabolic dysfunction-associated steatotic liver disease in mice 维生素D对小鼠高脂肪饮食诱导的代谢功能障碍相关脂肪变性肝病的保护作用
IF 2.3 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-11-17 DOI: 10.1016/j.steroids.2025.109718
Amal A. Mohamed , Wael Hafez , Said El-Feky , Mona G. Khalil , Amina S. Soliman , Karima Nasraldin , Ingy M. Ibrahim , Hanan A. Hegazy , Weam Shaheen , Abbas M. Abbas , Hager Shaheen , Marian FL. Abdelmalak , Hany N. Azzam , Omnia Ezzat , Noheir Ashraf Ibrahem Fathy Hassan , Omer Al Dulaimi , Naglaa K. Madkour

Background

Genetics, inflammation, and nutrition contribute to the pathogenesis of metabolic dysfunction–associated steatotic liver disease (MASLD).

Aim

This preclinical study evaluated the protective effect of vitamin D supplementation against high-fat-diet–induced MASLD in a mouse model and compared physiological, inflammatory, and molecular responses across high-fat and low-fat dietary regimens, with and without vitamin D co-administration.

Methods

Forty-five healthy male albino Swiss mice (aged 6 weeks; 30 ± 10 g) were randomly assigned to five groups (n = 9 each): control (standard diet), HFD (high-fat diet), HFD + vitamin D, LFD (low-fat diet), and LFD + vitamin D. Vitamin D (20 000 IU/kg/week) was administered via drinking water for 12 weeks. Body weight, visceral adiposity, and liver indices were recorded, while serum biochemical markers, inflammatory cytokines, and expression of Toll-like receptor 7 (TLR7) and microRNA-155 (miR-155) were analyzed at endpoint.

Results

HFD-fed mice exhibited marked increases in ALT (51.44 ± 9.68 U/L), AST (56.67 ± 13.29 U/L), ALP (135.01 ± 16.19 U/L), AFP (28.56 ± 5.31 ng/mL), CRP (20.87 ± 5.56 mg/L), total cholesterol (225.00 ± 27.16 mg/dL), LDL (137.56 ± 28.66 mg/dL), and triglycerides (210.56 ± 28.71 mg/dL), accompanied by reduced HDL (30.24 ± 9.86 mg/dL) compared with controls. Pro-inflammatory cytokines TNF-α (28.33 ± 2.96 pg/mL), IL-6 (121.78 ± 8.98 pg/mL), and the expression of TLR7 (2.92 ± 0.83) and miR-155 (2.75 ± 0.77) were significantly elevated relative to normal-fed mice (miR-155: 0.84 ± 0.26). Vitamin D supplementation significantly ameliorated these metabolic and inflammatory disturbances.

Conclusions

Vitamin D supplementation mitigated HFD-induced hepatic injury, dyslipidemia, and inflammatory activation by modulating the miR-155/TLR7 axis. These findings highlight vitamin D as a potential adjunctive strategy for preventing or attenuating MASLD progression under high-fat dietary conditions.
背景:遗传、炎症和营养与代谢功能障碍相关的脂肪变性肝病(MASLD)的发病机制有关。目的:本临床前研究在小鼠模型中评估了维生素D补充对高脂肪饮食诱导的MASLD的保护作用,并比较了高脂肪和低脂肪饮食方案在有和没有维生素D联合给药的情况下的生理、炎症和分子反应。方法:健康雄性瑞士白化小鼠45只(6 周,30 ± 10 g),随机分为5组(每组 = 9只):对照组(标准饮食)、HFD(高脂饮食)、HFD +维生素D、LFD(低脂饮食)和LFD +维生素D。维生素D(20000 IU/kg/周)通过饮用水给予,持续12 周。记录体重、内脏脂肪和肝脏指标,并在终点分析血清生化指标、炎症因子、toll样受体7 (TLR7)和microRNA-155 (miR-155)的表达。结果:HFD-fed老鼠表现出显著增加ALT(51.44 ±9.68 U / L)、AST(56.67 ±13.29 U / L),高山(135.01 ±16.19 U / L),法新社(28.56 ±5.31  ng / mL)、c反应蛋白(20.87 ±  5.56 mg / L),总胆固醇(225.00 ±27.16  mg / dL),低密度脂蛋白(137.56 ±28.66  mg / dL),和甘油三酯(210.56 ±28.71  mg / dL),伴随着降低高密度脂蛋白(30.24 ±9.86  mg / dL)与控制。 促炎细胞因子TNF -α(28.33±2.96  pg / mL), il - 6(121.78 ±8.98  pg / mL),和TLR7的表达式(2.92 ±0.83 )和mir - 155(2.75 ± 0.77)显著升高相对于normal-fed老鼠(mir - 155: 0.84 ±0.26 )。补充维生素D可显著改善这些代谢和炎症紊乱。结论:补充维生素D可通过调节miR-155/TLR7轴减轻hfd诱导的肝损伤、血脂异常和炎症激活。这些发现强调了维生素D作为预防或减轻高脂肪饮食条件下MASLD进展的潜在辅助策略。
{"title":"Protective effect of vitamin D on high-fat-diet-induced metabolic dysfunction-associated steatotic liver disease in mice","authors":"Amal A. Mohamed ,&nbsp;Wael Hafez ,&nbsp;Said El-Feky ,&nbsp;Mona G. Khalil ,&nbsp;Amina S. Soliman ,&nbsp;Karima Nasraldin ,&nbsp;Ingy M. Ibrahim ,&nbsp;Hanan A. Hegazy ,&nbsp;Weam Shaheen ,&nbsp;Abbas M. Abbas ,&nbsp;Hager Shaheen ,&nbsp;Marian FL. Abdelmalak ,&nbsp;Hany N. Azzam ,&nbsp;Omnia Ezzat ,&nbsp;Noheir Ashraf Ibrahem Fathy Hassan ,&nbsp;Omer Al Dulaimi ,&nbsp;Naglaa K. Madkour","doi":"10.1016/j.steroids.2025.109718","DOIUrl":"10.1016/j.steroids.2025.109718","url":null,"abstract":"<div><h3>Background</h3><div>Genetics, inflammation, and nutrition contribute to the pathogenesis of metabolic dysfunction–associated steatotic liver disease (MASLD).</div></div><div><h3>Aim</h3><div>This preclinical study evaluated the protective effect of vitamin D supplementation against high-fat-diet–induced MASLD in a mouse model and compared physiological, inflammatory, and molecular responses across high-fat and low-fat dietary regimens, with and without vitamin D co-administration.</div></div><div><h3>Methods</h3><div>Forty-five healthy male albino Swiss mice (aged 6 weeks; 30 ± 10 g) were randomly assigned to five groups (n = 9 each): control (standard diet), HFD (high-fat diet), HFD + vitamin D, LFD (low-fat diet), and LFD + vitamin D. Vitamin D (20 000 IU/kg/week) was administered via drinking water for 12 weeks. Body weight, visceral adiposity, and liver indices were recorded, while serum biochemical markers, inflammatory cytokines, and expression of Toll-like receptor 7 (TLR7) and microRNA-155 (miR-155) were analyzed at endpoint.</div></div><div><h3>Results</h3><div>HFD-fed mice exhibited marked increases in ALT (51.44 ± 9.68 U/L), AST (56.67 ± 13.29 U/L), ALP (135.01 ± 16.19 U/L), AFP (28.56 ± 5.31 ng/mL), CRP (20.87 ± 5.56 mg/L), total cholesterol (225.00 ± 27.16 mg/dL), LDL (137.56 ± 28.66 mg/dL), and triglycerides (210.56 ± 28.71 mg/dL), accompanied by reduced HDL (30.24 ± 9.86 mg/dL) compared with controls. Pro-inflammatory cytokines TNF-α (28.33 ± 2.96 pg/mL), IL-6 (121.78 ± 8.98 pg/mL), and the expression of TLR7 (2.92 ± 0.83) and miR-155 (2.75 ± 0.77) were significantly elevated relative to normal-fed mice (miR-155: 0.84 ± 0.26). Vitamin D supplementation significantly ameliorated these metabolic and inflammatory disturbances.</div></div><div><h3>Conclusions</h3><div>Vitamin D supplementation mitigated HFD-induced hepatic injury, dyslipidemia, and inflammatory activation by modulating the miR-155/TLR7 axis. These findings highlight vitamin D as a potential adjunctive strategy for preventing or attenuating MASLD progression under high-fat dietary conditions.</div></div>","PeriodicalId":21997,"journal":{"name":"Steroids","volume":"225 ","pages":"Article 109718"},"PeriodicalIF":2.3,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145557784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Steroids
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1